Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
Positive results in pre-clinical studies of the triple combination of elexacaftor, tezacaftor and ivacaftor, performed in airway epithelial cell cultures obtained from patients harbouring the class II cystic fibrosis transmembrane conductance regulator (CFTR) mutation F508del-CFTR, translated to imp...
Saved in:
Published in | The European respiratory journal Vol. 57; no. 6; p. 2002774 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
European Respiratory Society
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!